Selected Publications
Nead KT, Mitra N, Weathers B, Pyle L, Emechebe N, Pucci DA, Jacobs LA, Vaughn DJ, Nathanson KL, Kanetsky PA: Lower abdominal and pelvic radiation and testicular germ cell tumor risk
PLoS One
15 (11): e0239321,2020.
Haas NB, LaRiviere MJ, Buckingham TH, Cherkas Y, Calara-Nielsen K, Foulk B, Patel J, Gross S, Smirnov D, Vaughn DJ, Amaravadi R, Wellen KE, Savitch SL, Majmundar KJ, Black TA, Yee SS, He M, Min EJ, Long Q, Jones JO, Pal SK, Carpenter EL.: Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient response to abiraterone plus prednisone or enzalutamide.
Prostate Cancer Prostatic Disease : 2020.
McAndrew NP, Dickson MA, Clark AS, Troxel AB, O'Hara MH, Colameco C, Gallager M, Gramlich K, Zafman K, Vaughn D, Schwartz GK, O'Dwyer PJ, DeMichele A.: Early treatment-related neutropenia predicts response to palbociclib.
British Journal of Cancer 123 (6): 912-918,2020.
Trendowski MR, Wheeler HE, El Charif O, Feldman DR, Hamilton R, Vaughn DJ, Fung C, Kollmannsberger C, Einhorn LH, Travis LB, Dolan ME.: Clinical and genome-wide analysis of multiple severe cisplatin-induced neurotoxicities in adult-onset cancer survivors.
Clinical Cancer Research : 2020.
Morgan MA, Garratt JM, Vaughn DJ: What radiologists should know about microRNA (miRNA) serum biomarkers for germ cell tumors
Abdominal Radiology (NY) : 2020.
Morgan MA, Garratt JM, Vaughn DJ: What radiologists should know about microRNA (miRNA) serum biomarkers for germ cell tumors.
Abdominal Radiology (NY) : 2020.
Narayan V, Vaughn DJ, Ky B.:
Cardiovascular toxicities of therapy for genitourinary malignancies.
Urologic Oncology 38 (3): 121-128,2020.
Kerns SL, Fung C, Fossa SD, Dinh PC Jr, Monahan P, Sesso HD, Frisina RD, Feldman DR, Hamilton RJ, Vaughn D, Martin N, Huddart R, Kollmannsberger C, Sahasrabudhe D, Ardeshir-Rouhani-Fard S, Einhorn L, Travis LB.: Relationship of cisplatin-related adverse health outcomes With disability and unemployment among testicular cancer survivors.
Journal of the National Cancer Institue Cancer Spectrum 4 (4): pkaa022,2020.
Sadigh S, J Farahani S, Shah A, Vaughn D, Lal P.: Differences in PD-L1-expressing macrophages and immune microenvironment in testicular germ cell tumors. American Journal of Clinical Pathology
153 (3): 387-395,2020.
Parikh RB, Feld EK, Galsky MD, Adamson BJ, Cohen AB, Baxi SS, Boursi SB, Christodouleas JP, Vaughn DJ, Meropol NJ, Mamtani R.: First-line immune checkpoint inhibitor use in cisplatin-eligible patients with advanced urothelial carcinoma: a secular trend analysis.
Future Oncology 16 (2): 4341-4345,2020.
Academic Contact Information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-114
3400 Civic Center Blvd
Philadelphia,
PA
19104-4283
Phone: 215-349-8140
Patient appointments: 800-789-7366